LPL Financial
STOK icon

LPL Financial’s Stoke Therapeutics STOK Stock Holding History

LPL Financial’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676K Sell
20,645
-15,402
-43% -$494K ﹤0.01% 4766
2026
Q1 		$1.17M Buy
36,047
+28,667
+388% +$940K ﹤0.01% 4040
2025
Q4 		$234K Buy
+7,380
New +$222K ﹤0.01% 5345
2025
Q3 		– Sell
-12,604
Closed -$143K – 5984
2025
Q2 		$143K Buy
+12,604
New +$120K ﹤0.01% 5183

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LPL Financial's STOK Position: Q2 2026 in Review

LPL Financial reduced its Stoke Therapeutics (STOK) stake by 43% in Q2 2026, selling an estimated $494K and leaving 20,645 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #4766.

LPL Financial first reported a position in STOK in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.17M in Q1 2026. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • LPL Financial held 20,645 shares of Stoke Therapeutics worth $676K as of Q2 2026.
  • LPL Financial sold 15,402 Stoke Therapeutics shares in Q2 2026, an estimated $494K.
  • Stoke Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4766 holding.
  • LPL Financial first reported a position in Stoke Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • LPL Financial's Stoke Therapeutics position peaked at $1.17M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.